Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.05% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
XNCR · Jun 30, 2026
Xencor Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001326732-26-000056General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-108.66% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
17.46% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-72.37% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
140.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
17.95% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/6 normalizedAmended as filedJun 30, 20240/6 normalizedAmended as filedSep 30, 20240/6 normalizedAmended as filedDec 31, 20240/6 normalizedLevel 3Mar 31, 20250/6 normalizedLevel 3Jun 30, 20250/6 normalizedLevel 3Sep 30, 20250/6 normalizedLevel 3Dec 31, 20255/6 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20266/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 13.51%
- Current
- 1.05%
- Delta
- -12.46%
- Previous
- -1497.52%
- Current
- -108.66%
- Delta
- 1388.86%
- Previous
- -86.20%
- Current
- 17.46%
- Delta
- 103.66%
- Previous
- -1724.14%
- Current
- -72.37%
- Delta
- 1651.77%
- Previous
- 1432.00%
- Current
- 140.38%
- Delta
- -1291.62%
- Previous
- 211.71%
- Current
- 17.95%
- Delta
- -193.77%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Xencor Inc →Transitioned To · XNCR Fundamental State →Transitioned To · XNCR CAPEX_INTENSITY_DECREASED →Transitioned To · XNCR CASH_GENERATION_INCREASED →Transitioned To · XNCR GROWTH_INCREASED →Transitioned To · XNCR PROFITABILITY_INCREASED →Transitioned To · XNCR R_AND_D_INTENSITY_DECREASED →Transitioned To · XNCR SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.